First Trust Advisors
TNDM icon

First Trust Advisors’s Tandem Diabetes Care TNDM Stock Holding History

First Trust Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.57M Buy
+342,707
New +$7.45M ﹤0.01% 1302
2025
Q4 		– Sell
-40,730
Closed -$494K – 2714
2025
Q3 		$494K Buy
+40,730
New +$551K ﹤0.01% 2314
2025
Q2 		– Sell
-39,876
Closed -$764K – 2708
2025
Q1 		$764K Sell
39,876
-38,025
-49% -$1.11M ﹤0.01% 2127
2024
Q4 		$2.81M Sell
77,901
-21,204
-21% -$717K ﹤0.01% 1665
2024
Q3 		$4.2M Sell
99,105
-279,792
-74% -$11.9M ﹤0.01% 1418
2024
Q2 		$15.3M Buy
378,897
+36,027
+11% +$1.5M 0.02% 877
2024
Q1 		$12.1M Buy
+342,870
New +$9.19M 0.01% 962
2022
Q3 		– Sell
-133,481
Closed -$7.9M – 2605
2022
Q2 		$7.9M Sell
133,481
-119,392
-47% -$9.8M 0.01% 1036
2022
Q1 		$29.4M Buy
252,873
+52,798
+26% +$6.16M 0.03% 659
2021
Q4 		$30.1M Buy
200,075
+175,623
+718% +$23.7M 0.03% 670
2021
Q3 		$2.92M Buy
+24,452
New +$2.69M ﹤0.01% 1610
2021
Q2 		– Sell
-13,950
Closed -$1.23M – 2552
2021
Q1 		$1.23M Sell
13,950
-210,365
-94% -$19.6M ﹤0.01% 1918
2020
Q4 		$21.5M Sell
224,315
-67,756
-23% -$6.98M 0.03% 603
2020
Q3 		$33.1M Buy
292,071
+234,490
+407% +$24.6M 0.05% 422
2020
Q2 		$5.7M Buy
57,581
+10,902
+23% +$870K 0.01% 937
2020
Q1 		$3M Buy
46,679
+18,500
+66% +$1.3M 0.01% 1083
2019
Q4 		$1.68M Sell
28,179
-24,233
-46% -$1.49M ﹤0.01% 1649
2019
Q3 		$3.09M Buy
52,412
+8,362
+19% +$534K 0.01% 1286
2019
Q2 		$2.84M Sell
44,050
-22,407
-34% -$1.45M 0.01% 1370
2019
Q1 		$4.22M Sell
66,457
-13,517
-17% -$710K 0.01% 1115
2018
Q4 		$3.04M Buy
+79,974
New +$2.82M 0.01% 1239

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

First Trust Advisors's TNDM Position: Q1 2026 in Review

First Trust Advisors opened a new position in Tandem Diabetes Care (TNDM) in Q1 2026: 342,707 shares worth $6.57M. The stake represents ﹤0.01% of the portfolio and ranks #1302 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in TNDM as recently as Q3 2025.

First Trust Advisors first reported a position in TNDM in Q4 2018 and has held it in 21 quarters since. The position peaked at $33.1M in Q3 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • First Trust Advisors held 342,707 shares of Tandem Diabetes Care worth $6.57M as of Q1 2026.
  • Tandem Diabetes Care was a new First Trust Advisors position in Q1 2026.
  • Tandem Diabetes Care made up ﹤0.01% of First Trust Advisors's portfolio in Q1 2026, its #1302 holding.
  • First Trust Advisors first reported a position in Tandem Diabetes Care in Q4 2018 and has held it in 21 quarters since.
  • First Trust Advisors's Tandem Diabetes Care position peaked at $33.1M in Q3 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.